Skip to main content
. Author manuscript; available in PMC: 2012 Jul 18.
Published in final edited form as: Cell Immunol. 2011 Jul 18;271(1):110–117. doi: 10.1016/j.cellimm.2011.06.010

Fig. 4. Association of CD39 expression with T cell activation and medication usage.

Fig. 4

Correlation of proportion of CD39+ cells with CD69+ cells in (A) CD4+ Foxp3+ Treg populations and (B) CD4+ Foxp3− non-Treg populations among SLE patients (active and minimally active disease). Expression of CD39 (C) and CD69 (D) in Foxp3+ Tregs (C,D) and Foxp3− non-Tregs from SLE patients (active and minimally active disease), stratified by usage of nonsteroidal immunosuppressants (NSIS).